Bristol Myers Squibb · Pharmaceuticals & biotech
AI across biologics and cell-therapy production at BMS Devens
a 42% reduction in New Product Introduction (NPI) time
Case study · Pharmaceuticals & biotech
Pfizer needed to scale PAXLOVID production rapidly during the COVID-19 pandemic.
Manufacturer-reported This result comes from the manufacturer's own publications, such as newsroom posts, earnings materials or engineering blogs. It has not been independently verified.
Pfizer needed to scale PAXLOVID production rapidly during the COVID-19 pandemic.
Pfizer teams analyzed supply chain and production data with AI to identify, address and monitor production issues, creating a continuous-improvement loop.
Percent change as reported by the source; hover for the exact wording
AI analysis of supply chain and production data pinpointed and monitored bottlenecks in PAXLOVID manufacturing.
Outcomes as reported by the source. We do not adjust, combine or extrapolate reported figures.
Bristol Myers Squibb · Pharmaceuticals & biotech
a 42% reduction in New Product Introduction (NPI) time
Argos USA · Cement, glass & building materials
Demonstrated 28% reduction in energy consumption while maintaining product quality and improving throughput at the cement plant.
Georgia-Pacific · Paper & packaging
Demonstrated 40% reduction in defoamer usage, improving environmental impact of brownstock washing.
Novelis · Metals & fabrication
53% Scope 3 emissions
Put AI to work
Genvo, our implementation partner, works with manufacturers to pick the right first project, connect the systems you already run and put AI agents and tools into daily use, with people approving what goes out.
Assessments and consultations are provided by Genvo. How our partnership works.